Qualigen Therapeutics (NASDAQ: QLGN) Announces Executives,
Carlsbad, CA, Oct. 06, 2025 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) today announced a series of key leadership and governance changes aimed at strengthening its executive team, enhancing financial transparency, and supporting the Company’s next phase of strategic growth. Executive Appointments Effective October 2, 2025, Jerry (Jiawei) Wang was appointed as … Read more